The Latest Headlines at American Banking and Market News
Arch Resources’ (ARCH) Buy Rating Reaffirmed at Benchmark
Benchmark reiterated their buy rating on shares of Arch Resources (NYSE:ARCH – Free Report) in a report published on Monday morning, Benzinga reports. Benchmark currently has a $180.00 target price on the energy company’s... More of this article »
ATI (NYSE:ATI) Price Target Increased to $58.00 by Analysts at KeyCorp
ATI (NYSE:ATI – Free Report) had its price objective raised by KeyCorp from $56.00 to $58.00 in a research report sent to investors on Monday morning, Benzinga reports. They currently have an overweight rating on the basic materials... More of this article »
AMN Healthcare Services (NYSE:AMN) Price Target Lowered to $70.00 at Truist Financial
AMN Healthcare Services (NYSE:AMN – Free Report) had its target price cut by Truist Financial from $88.00 to $70.00 in a research report report published on Monday morning, Benzinga reports. They currently have a buy rating on... More of this article »
Aptiv (NYSE:APTV) Price Target Cut to $109.00 by Analysts at JPMorgan Chase & Co.
Aptiv (NYSE:APTV – Free Report) had its price objective trimmed by JPMorgan Chase & Co. from $110.00 to $109.00 in a research report report published on Monday morning, Benzinga reports. The firm currently has an overweight... More of this article »
Ameresco (NYSE:AMRC) Price Target Lowered to $37.00 at Truist Financial
Ameresco (NYSE:AMRC – Free Report) had its price target cut by Truist Financial from $40.00 to $37.00 in a report issued on Monday, Benzinga reports. They currently have a buy rating on the utilities provider’s stock. A... More of this article »
Avery Dennison (NYSE:AVY) Upgraded by StockNews.com to “Buy”
StockNews.com upgraded shares of Avery Dennison (NYSE:AVY – Free Report) from a hold rating to a buy rating in a report released on Monday. AVY has been the subject of several other reports. UBS Group raised their price target... More of this article »
Adient (NYSE:ADNT) Given New $37.00 Price Target at JPMorgan Chase & Co.
Adient (NYSE:ADNT – Free Report) had its price objective lowered by JPMorgan Chase & Co. from $40.00 to $37.00 in a research note issued to investors on Monday morning, Benzinga reports. The firm currently has a neutral... More of this article »
Algonquin Power & Utilities (NYSE:AQN) Given New $6.50 Price Target at Scotiabank
Algonquin Power & Utilities (NYSE:AQN – Free Report) had its price objective lowered by Scotiabank from $7.50 to $6.50 in a research report released on Monday, MarketBeat.com reports. The firm currently has a sector perform... More of this article »
Altus Power (NYSE:AMPS) Price Target Cut to $7.00 by Analysts at B. Riley
Altus Power (NYSE:AMPS – Free Report) had its price objective trimmed by B. Riley from $10.00 to $7.00 in a report released on Monday morning, Benzinga reports. The firm currently has a buy rating on the stock. A number of other... More of this article »
Agnico Eagle Mines (NYSE:AEM) Price Target Increased to $57.00 by Analysts at Jefferies Financial Group
Agnico Eagle Mines (NYSE:AEM – Free Report) (TSE:AEM) had its target price boosted by Jefferies Financial Group from $54.00 to $57.00 in a report issued on Monday, BayStreet.CA reports. They currently have a hold rating on the... More of this article »
American Express (NYSE:AXP) Given New $175.00 Price Target at BMO Capital Markets
American Express (NYSE:AXP) had its price objective boosted by BMO Capital Markets from $167.00 to $175.00 in a research report sent to investors on Monday morning, Benzinga reports. The brokerage currently has an underperform rating... More of this article »
AECOM (NYSE:ACM) Price Target Increased to $116.00 by Analysts at Citigroup
AECOM (NYSE:ACM – Free Report) had its target price boosted by Citigroup from $107.00 to $116.00 in a research note issued to investors on Monday, Benzinga reports. Citigroup currently has a buy rating on the construction company’s... More of this article »
Abbott Laboratories (NYSE:ABT) Price Target Cut to $140.00 by Analysts at Barclays
Abbott Laboratories (NYSE:ABT – Free Report) had its target price cut by Barclays from $141.00 to $140.00 in a research report sent to investors on Monday morning, Benzinga reports. They currently have an overweight rating on... More of this article »